Kilitch Drugs hits new high; stock zooms 51% in January
The stock hit a new high of Rs 242, rallied 51% thus far in the month of January.23-01-2019
23-01-2019
Kilitch Drugs India Ltd - 524500 - Shareholding for the Period Ended December 31, 2018
Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here18-01-2019
KILITCH DRUGS (INDIA) LTD. - 524500 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Harshal PatilDesignation :- Company Secretary and Compliance Officer17-01-2019
Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are pleased to enclosed herewith our Press Release relating to Financial Results of Quarter-2 of Financial Year 2018-19.12-11-2018
Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results Of The Company For The Quarter/Half Year Ended September 30, 2018 And To Consider The Re-Appointment Of Mrs. Mira Mehta As A Whole-Time Director Of The Company.
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2018 ,inter alia, to consider and approve To consider and approve the un-audited financial results of the company for the quarter/half year ended September 30, 2018 and to consider the re-appointment of Mrs. Mira Mehta as a Whole-time Director of the Company.31-10-2018
Statement Of Deviation Or Variation Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herewith Statement Of Deviation Or Variation for the quarter ended 30th September, 2018.29-10-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are pleased to enclosed herewith our Press Release relating to start of manufacturing operations in Ethopia,24-10-2018
Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Mukund MehtaDesignation :- Director20-10-2018
Compliance Certificate Under Regulation 40(9) Of The SEBI(Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 2018
Please find enclosed herewith Compliance Certificate Under Regulation 40(9) Of The SEBI(Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 201820-10-2018